CTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo226;132;162; for Treatment of Niemann-Pick Disease Type C

Press/Media: Press / Media

PeriodOct 6 2018

Media coverage

1

Media coverage

  • TitleCTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo226;132;162; for Treatment of Niemann-Pick Disease Type C
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date10/6/18
    PersonsDarius Adams